DNTH

82.6302.59%
SR

Simrat Randhawa

Executive VP and Head of R&D

Dr. Simrat Randhawa, M.D., M.B.A., serves as Executive Vice President and Head of R&D at Dianthus Therapeutics, Inc. since October 01, 2025 and served as its Chief Medical Officer since September 2023 until 2025 and Former Chief Medical Officer at Dianthus since April 2022. He had been Senior Vice President of Clinical & Medical Affairs at Aurinia Pharmaceuticals Inc. since March 2019 and had been its Head of Global Medical Affairs from August 08, 2017 to March 2019. He has extensive experience across clinical practice, medical affairs and business development. He transitioned out of clinical medicine and into McKinsey Consulting focusing on the life sciences where he evaluated business development opportunities for top-tier biopharma clients. For many years, he has held a number of senior leadership roles in commercial and medical affairs within large and small pharmaceutical companies. He served as the global medical affairs lead at BioMarin Pharmaceuticals for MPS, Duchenne Muscular Dystrophy and Hemophilia. He completed his M.D. at Drexel University and received his M.B.A. from Columbia University. He completed his training in general surgery at Robert Wood Johnson University Hospital in New Brunswick, NJ.

Positions